Literature DB >> 9740913

ASHP statement on the pharmacist's role in clinical pharmacokinetic monitoring.

.   

Abstract

Mesh：

Year:  1998        PMID： 9740913     DOI： 10.1093/ajhp/55.16.1726

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN： 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  5 in total

1.  Development and implementation of a pharmacist-managed clinical pharmacogenetics service.

Authors:  Kristine R Crews; Shane J Cross; John N McCormick; Donald K Baker; Alejandro R Molinelli; Richard Mullins; Mary V Relling; James M Hoffman
Journal:  Am J Health Syst Pharm       Date:  2011-01-15       Impact factor: 2.637

2.  Knowledge, Confidence, and Perception Toward Therapeutic Drug Monitoring Among Physicians and Pharmacists in Kuwait.

Authors:  Abdullah Albassam; Sarah S Alghanem; Farah Alawadhi; Zainab Alsulaimani
Journal:  Ther Drug Monit       Date:  2022-02-08       Impact factor: 3.118

3.  A survey of therapeutic drug monitoring in a teaching hospital.

Authors:  Shahad Almohammde; Hadil Alhodian; Sara Almofareh; Samah Alshehri; Diena M Almasri; Ragia H Ghoneim
Journal:  Saudi J Biol Sci       Date:  2020-11-11       Impact factor: 4.219

4.  Reintroduction of Post-Baccalaureate Doctor of Pharmacy (PharmD, Post-Bac) Program in Nepal: Exploration of the Obstacles and Solutions to Move Forward.

Authors:  Sunil Shrestha; Sweta Shrestha; Binaya Sapkota; Rajani Shakya; Rohullah Roien; Mohamed Izham Mohamed Ibrahim
Journal:  Adv Med Educ Pract       Date:  2022-02-18

5.  Practical approaches to improve vancomycin-related patient outcomes in pediatrics- an alternative strategy when AUC/MIC is not feasible.

Authors:  Kashif Hussain; Muhammad Sohail Salat; Shahzad Rauf; Manoj Rathi; Midhat Khan; Fizzah Naz; Wasif Ahmed Khan; Rahila Ikram; Gul Ambreen
Journal:  BMC Pharmacol Toxicol       Date:  2022-08-20       Impact factor: 2.605
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.